Induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally-advanced esophageal and gastroesophageal junction cancer: A phase II study

MLA

Richard Francis Dunne, et al. “Induction FOLFOX Prior to CROSS Chemoradiotherapy and Surgery in Patients with Locally-Advanced Esophageal and Gastroesophageal Junction Cancer: A Phase II Study.” Journal of Clinical Oncology, vol. 40, Feb. 2022, p. 327. EBSCOhost, https://doi.org/10.1200/jco.2022.40.4_suppl.327.

APA

Richard Francis Dunne, Nabeel Badri, Maria Nicolais, Marcus Smith Noel, Andrea M. Baran, Wenjia Wang, Erika E. Ramsdale, Jason Zittel, Haoming Qiu, Alan W. Katz, Carolyn E. Jones, Christian G. Peyre, Michal J. Lada, Aram F Hezel, & Mohamedtaki Abdulaziz Tejani. (2022). Induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally-advanced esophageal and gastroesophageal junction cancer: A phase II study. Journal of Clinical Oncology, 40, 327. https://doi.org/10.1200/jco.2022.40.4_suppl.327

Chicago

Richard Francis Dunne, Nabeel Badri, Maria Nicolais, Marcus Smith Noel, Andrea M. Baran, Wenjia Wang, Erika E. Ramsdale, et al. 2022. “Induction FOLFOX Prior to CROSS Chemoradiotherapy and Surgery in Patients with Locally-Advanced Esophageal and Gastroesophageal Junction Cancer: A Phase II Study.” Journal of Clinical Oncology 40 (February): 327. doi:10.1200/jco.2022.40.4_suppl.327.